Infection with the oncogenic human papillomavirus type 59 alters protein components of the cornified cell envelope

Virology

Volumn 309, Issue 1, 2003, Pages 53-60

  Lehr, Elizabeth ^a   Brown, Darron R ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 10; INVOLUCRIN; LORICRIN; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; GENITAL SYSTEM; GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKIN EPITHELIUM; TRANSCRIPTION REGULATION; VIRION; VIRUS REPLICATION; VIRUS TRANSMISSION; WART VIRUS; XENOGRAFT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0037466533     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00100-9     Document Type: Article

References (27)

1. Brown D., Bryan J. Abnormalities of cornified cell envelopes isolated from human papillomavirus type 11-infected genital epithelium. Virology. 271:2000;65-70.
2. Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J. Clin. Microbiol. 37:1999;3316-3322.
3. Bryan J., Brown D. Transmission of human papillomavirus type 11 infection by desquamated cornified cells. Virology. 281:2001;35-42.
4. Bryan, J., Tekchandani, J., Schroeder J., and Brown, D. 2000. Propagation of human papillomavirus type 59 in the athymic mouse xenograft system. Intervirology 526, in press.
5. Candi E., Melino G., Mei G., Tarcsa E., Chung S., Marekov L., Steinert P. Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J. Biol. Chem. 270:1995;26382-26390.
6. Doorbar J., Foo C., Coleman N., Medcalf L., Hartley O., Prospero T., Napthine S., Sterling J., Winter G., Griffin H. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology. 238:1997;40-52.
7. Eckert R., Crish J., Robinson N. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77:1997;397-424.
8. Heller-Milev, Huber, M., Panizzon, R., Hohl, D. (2000). Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. Br. J. Dermatol. 143, 733-740.
9. Hohl D., Mehrel T., Lichti U., Turner M., Roop D., Steinert P. Characterization of human loricrin. J. Biol. Chem. 266:1991;6626-6636.
10. Hohl D., Viragh P., Amiguet-Barras F., Gibbs S., Backendorf C., Huber M. The small proline-rich protein constitute a multigene family of differentially regulated cornified cell envelope precursor protein. J. Invest. Dermatol. 104:1995;902-909.
11. Howley P.M. Papillomavirinae the viruses and their replication . Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monrath T.P., Roizman B., Strasu S.E. Fields Virology. third ed. 1996;2045-2076 Lippincott-Raven, Philadelphia.
12. Jarnik M., Simon M., Steven A. Cornified cell envelope assembly a model based on electron microscopic determinations of thickness and projected density . J. Cell Sci. 111:1998;1051-1060.
13. Koutsky L. Epidemiology of genital human papillomavirus infection. Am. J. Med. 102:1997;3-8.
14. Kubilus J., Baden H. Isopeptide bond formation in epidermis. Mol. Cell. Biochem. 58:1984;129-137.
15. Lehr E., Jarnik M., Brown D. Human papillomavirus type 11 alters transcription and expression of loricrin, the major cell envelope protein. Virology. 298:2002;240-247.
16. Marvin K., George M., Fujimoto W., Saunders N., Bernacki S., Jetten A. Cornifin, a cross-linked envelope precursor in keratinocytes that is down-regulated by retinoids. Proc. Nat. Acad. Sci. 89:1992;11026-11030.
17. Ming M., Daryanani H., Roberts L., Baden H., Kvedar J. Binding of keratin intermediate filaments (K10) to the cornified envelope in mouse epidermis implications for barrier function . J. Inves. Dermatol. 103:1994;780-784.
18. Nemes Z., Steinert P. Bricks and mortar of the epidermal barrier. Exp. Mol. Med. 31:1999;5-19.
19. Pray T.R., Laimins L.A. Differentiation-dependent expression of E1^E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology. 206:1995;679-685.
20. Rice R., Green H. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell. 11:1977;417-422.
21. Robinson N., Lacelle P., Eckert R. Involucrin is a covalently crosslinked constituent of highly purified epidermal corneocytes evidence for a common pattern of involucrin crosslinking in vivo and in vitro . J. Inves. Dermatol. 107:1996;101-107.
22. Robinson N., Lapic S., Welter J., Eckert R. S100A11, S100A10, annexin I, desmosmal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J. Biol. Chem. 272:1997;12035-12046.
23. Steinert P., Candi E., Kartasova T., Marekov L. Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia. J. Struct. Biol. 122:1998;76-85.
24. Steinert P., Marekov L. Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope. J. Biol. Chem. 272:1997;2021-2030.
25. Steven A., Steinert P. Protein composition of cornified cell envelopes of epidermal keratinocytes. J. Cell Sci. 107:1994;693-700.
26. Yaffe M., Murthy S., Eckert R. Evidence that involucrin is a covalently linked constituent of highly purified cultured keratinocyte cornified envelopes. J. Invest. Dermatol. 100:1993;3-9.
27. ZurHausen H. Viruses in human cancers. Eur. J. Cancer. 35:1999;1174-1181.